Jan Stenvang
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- Extracellular vesicles in disease
- DNA and Nucleic Acid Chemistry
Papers in
-
- Cancer therapeutics and mechanisms 16
- RNA Interference and Gene Delivery 10
- Advanced biosensing and bioanalysis techniques 8
- Oncology 31
- Drug Transport and Resistance Mechanisms 12
- Colorectal Cancer Treatments and Studies 6
- Co-authors
- Sakari Kauppinen (10 shared papers)Morten Lindow (4 shared papers)Susanna Obad (4 shared papers)Andreas Petri (3 shared papers)Simon Fredriksson (4 shared papers)Martin Lundberg (3 shared papers)Jesper Wengel (3 shared papers)Erika Assarsson (2 shared papers)
In The Last Decade
Jan Stenvang
91 papers receiving 5.5k citations
Jan Stenvang's Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 2.0k
- Molecular Biology 3.2k
- Oncology 687
- Immunology 502
- Genetics 196
Countries citing papers authored by Jan Stenvang
This map shows the geographic impact of Jan Stenvang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Stenvang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Stenvang more than expected).
Fields of papers citing papers by Jan Stenvang
This network shows the impact of papers produced by Jan Stenvang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Stenvang. The network helps show where Jan Stenvang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Stenvang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability Hit paper breakdown → | 2014 | 1201 |
| 2 | Silencing of microRNA families by seed-targeting tiny LNAs Hit paper breakdown → | 2011 | 533 |
| 3 | 2012 | 459 | |
| 4 | 2011 | 427 | |
| 5 | 2010 | 270 | |
| 6 | 2009 | 171 | |
| 7 | 2008 | 165 | |
| 8 | 2004 | 155 | |
| 9 | 2008 | 134 | |
| 10 | 2016 | 104 | |
| 11 | 2017 | 103 | |
| 12 | 2017 | 102 | |
| 13 | 2012 | 98 | |
| 14 | 2016 | 96 | |
| 15 | 2007 | 92 | |
| 16 | 2013 | 80 | |
| 17 | 1999 | 73 | |
| 18 | 2017 | 65 | |
| 19 | LNA-antisense rivals siRNA for gene silencing. | 2004 | 63 |
| 20 | 2017 | 52 |
About Jan Stenvang
Jan Stenvang is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 94 papers that have together received 5.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), Cancer therapeutics and mechanisms (16 papers), Drug Transport and Resistance Mechanisms (12 papers), RNA Interference and Gene Delivery (10 papers), Cancer-related molecular mechanisms research (9 papers), Advanced biosensing and bioanalysis techniques (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (3.2k citations), Oncology (687 citations), Immunology (502 citations) and Genetics (196 citations). Jan Stenvang has collaborated with scholars based in Denmark, China and Germany. Frequent co-authors include Sakari Kauppinen, Morten Lindow, Susanna Obad, Andreas Petri, Simon Fredriksson, Martin Lundberg, Jesper Wengel, Erika Assarsson, Daniel Ekman and Göran Holmquist. Their work appears in journals such as BMC Cancer, Cancer Research, Journal of Clinical Oncology, Molecular Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.